Ping An Good Doctor Reports 2025 Annual Results: Corporate Health Management Business Posts Strong Growth; AI Healthcare Deployment Accelerates
HONG KONG, March 24, 2026 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or the "Company"; Stock Code: 1833.HK) announced its annual results for the year ended December 31, 2025. In 2025, the Company...
HKeyBio Launches HKEY-NHP-onChip™ 1.1: World's First NHP In Vitro Model for Autoimmune and Allergic Diseases
The integrated organ-on-chip platform offers 10–100x cost efficiency and 80% reduction in animal use, bridging the gap between preclinical NHP research and human clinical success. SUZHOU, China, SAN FRANCISCO and BOSTON, March 24, 2026 /PRNewswire/...
X Square Robot and Global Partners Launch ManipArena at CVPR 2026
The launch sets a new global benchmark for evaluating real-world embodied intelligence SHENZHEN, China, March 24, 2026 /PRNewswire/ -- X Square Robot, a pioneer in general purpose embodied intelligence, announced today its pivotal role as a founding...
Erayak Power Solution Strategic Update: Accelerating High-Capacity UPS-Integrated Platforms to Support AI-Driven Energy Demand
Prototype preview expected at the 2026 National Hardware Show as Ruike Electronics facility advances WENZHOU, China, March 24, 2026 /PRNewswire/ -- Erayak Power Solution Group Inc. (Nasdaq: RAYA) ("Erayak" or the "Company"), a developer and...
Agero Receives Frost & Sullivan's 2025 North American Digitalized Roadside Assistance Services Company of the Year Recognition for Market Leadership Excellence
The company is honored for redefining industrial performance through GenAI copilots, automation, and innovation that deliver measurable returns by improving efficiency and reducing downtime. SAN ANTONIO, March 24, 2026 /PRNewswire/ -- Frost &...
Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study
Collaboration supports IND-enabling development and a planned Phase 1/2a first-in-human clinical study in type 1 diabetes CARY, N.C. and NEW YORK, March 24, 2026 /PRNewswire/ -- Continuity Biosciences and Breakthrough T1D, the leading global type 1...
Discovery Life Sciences and Mindpeak Partner to Bring AI Precision to Cancer Biomarker Testing in Global Clinical Trials
New alliance takes aim at inconsistent biomarker interpretation across pathologists, a persistent challenge in drug development HUNTSVILLE, Ala. and HAMBURG, Germany, March 24, 2026 /PRNewswire/ -- Inconsistent biomarker interpretation across...
Dynacast Expands Integrated Manufacturing Capabilities with Addition of Platinadora Baja
CHARLOTTE, N.C., March 24, 2026 /PRNewswire/ -- Form Technologies, the parent company of Dynacast, a global leader in precision die casting, announced today the acquisition of Platinadora Baja, expanding Dynacast's integrated manufacturing...